Easier Access to Innovative Drugs in Medicare Program
This bill introduces a new appeal process for Medicare decisions that deny or limit access to approved drugs. Citizens will have the opportunity to comment on these decisions, which may accelerate access to new therapies and ensure greater transparency in the drug approval process.
Key points
Establishes a review process for Medicare decisions denying coverage for approved drugs.
Introduces a 30-day public comment period for drug coverage determinations.
Prohibits applying old Medicare decisions to newly approved drugs if it limits access.
Ensures prescription drug plans cannot deny coverage based on outdated determinations.
Expired
Citizen Poll